List of insiders holdings for TransMedics Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures 2007 General Partner LLC Flagship Ventures Fund 2007 L.P. AFEYAN NOUBAR 10% Owner | 2019-10-31 19:00:29 | 0 2,960,786 | 2,960,786 | Form 4 |
| ABRAMS CAPITAL MANAGEMENT L.P. ABRAMS CAPITAL MANAGEMENT LLC Abrams Capital Partners II L.P. ABRAMS CAPITAL LLC Abrams David C Riva Capital Partners III L.P. Riva Capital Management III LLC 10% Owner | 2021-02-16 16:01:08 | 1,302,612 0 | 1,302,612 | Form 13G |
| Hassanein Waleed H President & CEO | 2024-05-08 16:31:19 | 209,643 469,359 | 679,002 | Form 4 |
| KANIA EDWIN M JR Director | 2023-05-30 16:37:04 | 259,860 46,142 | 306,002 | Form 4 |
| TOBIN JAMES R Director | 2024-05-07 16:30:12 | 1193 193,146 | 194,339 | Form 4 |
| Godhani Rakesh P. Chief Digital Officer | 2021-08-06 17:05:31 | 140,000 0 | 140,000 | Form 4 |
| Provost Miriam VP, Global Regulatory Affairs | 2023-12-15 17:31:17 | 46,045 0 | 46,045 | Form 4 |
| Gordon Stephen Chief Financial Officer | 2024-05-08 16:33:07 | 45,776 0 | 45,776 | Form 4 |
| Khayal Tamer I Chief Commercial Officer | 2024-05-08 16:32:24 | 23,975 11,051 | 35,026 | Form 4 |
| Carey John F VP of Operations | 2023-02-03 17:12:57 | 32,550 0 | 32,550 | Form 4 |
| Sullivan John F VP of Quality & Engineering | 2021-09-01 17:04:44 | 30,045 0 | 30,045 | Form 4 |
| Ranganath Anil P. See remarks | 2023-08-04 17:16:01 | 24,221 0 | 24,221 | Form 4 |
| Corcoran Nicholas See Remarks | 2024-05-08 16:35:08 | 21,105 0 | 21,105 | Form 4 |
| DAMME LAURA VP, Clinical Affairs | 2023-02-22 20:00:40 | 14,390 0 | 14,390 | Form 4 |
| Weill David Director | 2023-08-30 16:33:46 | 13,693 0 | 13,693 | Form 4 |
| RAINES MERILEE Director | 2023-05-30 16:31:38 | 3109 0 | 3109 | Form 4 |
| Gunderson Thomas James Director | 2023-05-30 16:30:53 | 3109 0 | 3109 | Form 4 |
| Lovell Stephanie Director | 2023-05-30 16:30:38 | 3109 0 | 3109 | Form 4 |
| Basile Edward M Director | 2024-05-08 16:32:40 | 1193 0 | 1193 | Form 4 |
| UNITED THERAPEUTICS Corp Lung Biotechnology PBC 10% Owner | 2021-02-05 06:04:18 | 0 0 | 0 | Form 13G |
| Gilbert James Director | 2019-05-01 19:06:22 | 0 0 | 0 | Form 3 |